Skip to content
CA.gov logo in white
  • Grants Management System
  • CIRM Hub Portal
  • Contact
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops
  • About
    • Our Mission
    • Our Impact
    • Our Governing Board
    • Strategic Goals
    • Our Team
    • Annual Reports
  • For Researchers
    • Explore Funding Opportunities
    • How to Apply
    • Our Review Process
    • Manage Your Award
  • Our Programs
    • Grants Dashboard
    • Research and Development
    • Education and Training
    • Patient Access
  • Patient Resources
    • Stem Cell and Genetic Research
    • From Bench to Bedside
    • Community Outreach
    • Clinical Trials
    • Community Stories
  • News and Events
    • Press Releases
    • Public Meetings
    • Blog
    • Webinars and Workshops

Neural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

  • Post author:
  • Post published:October 16, 2026
  • Post category:

Alzheimer disease (AD), the most common cause of dementia among the elderly and the third leading cause of death, presently afflicts over 5 million people in the USA, including over…

Continue ReadingNeural Stem Cells as a Developmental Candidate to Treat Alzheimer Disease

Sustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

  • Post author:
  • Post published:October 16, 2026
  • Post category:

One in every ten thousand people in the USA have Huntington's Disease, and it impacts many more. Multiple generations within a family can inherit the disease, resulting in escalating health…

Continue ReadingSustained siRNA production from human MSC to treat Huntingtons Disease and other neurodegenerative disorders

Stem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)

  • Post author:
  • Post published:October 16, 2026
  • Post category:

Brain tumors (BTs) are incurable, whether they start in the brain or spread there from other sites. Despite advances in surgical, radiation, pharmacologic, and gene therapies, survival with a BT…

Continue ReadingStem Cell-Mediated Oncocidal Gene Therapy of Glioblastoma (GBM)

Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials

  • Post author:
  • Post published:October 16, 2026
  • Post category:

Despite aggressive multimodal therapy and advances in imaging, surgical and radiation techniques, malignant brain tumors (high-grade gliomas) remain incurable, with survival often measured in months. Treatment failure is largely attributable…

Continue ReadingStem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials

Hypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Continue ReadingHypoimmune Stem Cell–Derived Islets: A Next-Generation Cell Therapy Toward a Functional Cure for Type 1 Diabetes

Stem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Continue ReadingStem Cell-Engineered Off-The-Shelf CAR-NKT Cell Therapy for Multiple Sclerosis

Microglia replacement therapy for CSF1R-related Leukoencephalopathy

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Continue ReadingMicroglia replacement therapy for CSF1R-related Leukoencephalopathy

Development of universal off-the-shelf iPSC derived dendritic cells for use as patient specific anti-tumor vaccine

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Research Objective This proposal aims to develop a novel cell based vaccine for the treatment of cancer. The vaccine would be derived from stem cells and be personalized to the…

Continue ReadingDevelopment of universal off-the-shelf iPSC derived dendritic cells for use as patient specific anti-tumor vaccine

Battling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Research Objective allogeneic HSC-engineered iNKT (HSC-iNKT) cells Impact treatment for COVID-19 Major Proposed Activities Milestone 1. Production of AlloHSC-iNKT and UHSC-iNKT cellsMilestone 2. Characterization of the AlloHSC-iNKT and UHSC-iNKT cellsMilestone…

Continue ReadingBattling COVID-19 Using Off-The-Shelf HSC-Engineered iNKT Cells

Chimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2

  • Post author:
  • Post published:October 15, 2026
  • Post category:

Research Objective We expect to generate iPSC derived NK cells expressing a CAR against SARS-cov2 that could be used as an off-the-shelf therapy for COVID-19 Impact The proposed studies will…

Continue ReadingChimeric Antigen Receptor Targeting Spike Glycoprotein of SARS-cov2
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page
  • Careers
  • Administrative & Financials
  • Accessibility

Subscribe to Receive CIRM News

Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox. 

Sign Up
Facebook-f X-twitter Instagram Linkedin Youtube
  • Privacy Policy
  • ©2025 California Institute for Regenerative Medicine
  • Media Guidelines
  • Contact Us